Sponsorship Prospectus V3.0nzbcs.org.nz/uploads/NZBCS2020/sponsorshipprospectus2021.pdfSociety of...

1 | P a g e

NZBCS‐2021

Thursday 18 - Saturday 20 November 2021 Auckland University of Technology (AUT)

Auckland, New Zealand

The2ndNewZealandBreastCancerSymposium

Web: www.nzbcs.org.nz Email: [email protected]

DetectionResearch

Treatment

OrganisedbytheNZAssociationofBreastCancerResearchinassociationwiththeBreastCancerFoundationNZ

2 | P a g e

The New Zealand Association of Breast Cancer Research Incorporated (NZABC® Inc.) invites your company /organisation to sponsor the second New Zealand Breast Cancer Symposium in 2021 (NZBCS-2021), which will be held in Auckland, New Zealand from 18-20th November 2021. The conference will be hosted by the School of Science, Faculty of Health and Environmental Sciences of the Auckland University of Technology (AUT), in association with the major breast cancer charities in New Zealand.

NZBCS is a triennial international conference for widespread dissemination of the latest advancement in breast cancer research. The inaugural NZBCS conference was held in 2017 and was attended by many local researchers, clinicians and health professionals as well as delegates from over 25 other countries. NZBCS-2021 continues to serve as a global forum for researchers to present research findings, share ideas and keep abreast of the latest progress of breast cancer detection technologies, research methodologies and treatment options.

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death among women worldwide. Each year, more than 2 million new cases and 627,000 deaths are reported. The incidence rate of breast cancer in New Zealand is among the highest in the world. Breast cancer affects one in nine New Zealand females in their lifetime. Although male breast cancer is rare, men may suffer from it at a much lower rate. In New Zealand, about one percent of all breast cancers are in men. Research has played a critical role in reducing breast cancer incidence and mortality rates in the last decades.

NZABC® Inc. is a non-profit scientific organisation for breast cancer research and was established at the inaugural NZBCS-2017 conference. Its vision is to be "United for a Cure Through Research” and help those with breast cancer to live longer. NZBCS-2021 will continue to promote basic and clinical research on breast cancer, stimulate domestic and international collaborations, and expedite the translation of laboratory discoveries into clinical applications, ultimately for improved treatment of those with breast cancer.

NZBCS-2021 conference is the ideal event to promote your company/organisation’s profile and strengths to the world, whilst also forging significant multilateral networks and collaborations in health sectors and pharmaceutical industries.

We invite you to consider the sponsorship opportunities detailed in this prospectus. Please do not hesitate to contact us by emailing [email protected] for any assistance in becoming a sponsor of this prestigious event.

We look forward to your support and participation in NZBCS-2021 conference.

Yours sincerely,

A/Professor Dong-Xu Liu Professor Ian Campbell President, NZABC® Inc. Vice President, NZABC® Inc. Chair, Organising Committee, NZBCS-2021 Chair, Scientific Committee, NZBCS-2021 Web: http://www.nzbcs.org.nz Email: [email protected]

3 | P a g e

The Second New Zealand Breast Cancer Symposium

Contact: A/Professor Dong‐Xu Liu, BSc MSc PhD, Auckland University of Technology, C‐42, Private Bag 92006, Auckland 1142, New Zealand.

Email: [email protected]; Tel: +64 9 921 9999 ext. 6722.

NZBCS‐2021 18th‐20th November 2021, Auckland, New Zealand. Email: [email protected]; Web: www.nzbcs.org.nz

The NZ Breast Cancer Symposium (NZBCS) is a triennial international conference on breast cancer research, serving as a robust global forum for researchers to disseminate research findings and share ideas in breast cancer detection, research and treatment.

The conference will be held in Auckland, a major city in the north of New Zealand’s North Island. The city has been within the 10 most liveable cities in the global liveability survey of 140 cities.

WHAT IS NZBCS?

NZBCS-2021 will be organised by the New Zealand Association of Breast Cancer Research Incorporated (NZABC® Inc.), hosted by the Auckland University of Technology (AUT), in association with major breast cancer charities in New Zealand. They include: Breast Cancer Foundation New Zealand

(BCFNZ); Breast Cancer Cure (BCC); Breast Cancer Support Service Tauranga Trust; Waikato Breast Cancer Research Trust; and Breast Cancer Support Inc.

The symposium will be attended by: High profile keynote speakers; Researchers and academics; Clinicians and nurses; Health professionals; Industry leaders; Local government representatives; and General public and those with a special interest

in breast cancer.

Delegates from over 25 countries attended the inaugural NZBCS-2017, including China; Korea; Australia; Singapore; USA; Pakistan; India; Iran; Germany; Brazil; Canada; Czech; France; Sweden;

Programme: Thursday 18th November, 2021 Friday 19th November, 2021 Saturday 20th November, 2021

Sponsorship will uniquely position your company or institution to take full advantage of the promotional and collaborative benefits of NZBCS-2021. These benefits will allow you to: Strengthen your profile as a key manufacturer or

supplier in breast cancer research and treatment technology sectors

Increase brand awareness and recognition through:

o Face-to-face exposure o Website advertising o Printed conference materials

Showcase and promote your activities, products and/or services

Demonstrate your commitment to the improvement of the life quality of those affected by breast cancer

Gain knowledge from delegates that include researchers and oncologists

Understand existing and future needs in the field Generate collaborations and networks by

building relationships

WHO IS INVOLVED?

WHEN IS THE EVENT?

WHERE WILL IT BE HELD?

UK; Indonesia; Israel; Italy; Lithuania; Poland; Thailand; Malaysia; Tunisia; Turkey; and New Zealand.

WHY SPONSOR?

4 | P a g e





Prof Ian Ellis, BMedSci, BM MS, FRCPath, Nottingham City Hospital, Nottingham, UK

Ian Ellis is Professor of Cancer Pathology, Nottingham University and an Honorary Consultant Pathologist at the Nottingham City Hospital. He has been involved in the practice of pathology for 35 years and has an international reputation in clinical and translational research in breast disease, particularly classification and molecular pathology of breast cancer and evaluation of prognostic factors. He is author of over 700 peer reviewed scientific publications, chapters in medical textbooks and specialist textbooks in pathology and an experienced lecturer being a founder member of the faculty of the Nottingham Blamey International Breast Education Centre.

He is a Past President of the Pathological Society of Great Britain and Ireland. He has been Specialty Advisor to The Royal College of Pathologists, and is past Chairman of the UK National Co-ordinating Committee for Breast Pathology. He has acted as an advisor to the DoH, UICC, WHO and IARC. He is Medical Director of Source Bioscience plc. He retired from his full time University and honorary NHS consultant post at the end of August 2015, returning on a part time basis in October 2015.

He was named in 2010 as one of the top 20 most influential people in the field of breast cancer research in the world and one of just four UK scientists in the list compiled from a field of 44,000 scientists around the globe; as No 8 in the top 100 most influential laboratory medicine professionals in the World in a survey carried out by The Pathologist in 2015; and as on of the top 100 Pathologists Worldwide by The Pathologist in The Pathologist’s Power List 2018. His other awards included Honorary Fellowship of the Royal College of Pathologists of Australia in 2011, The Presidents Medal, British Division of the International Academy of Pathology in 2014, NHS Clinical Excellence Award – Platinum in 2015, The Ritchie Medal by the Pathological Society of Great Britain and Ireland in 2016, and first recipient of the BCRF-Larry Norton Award for Excellence in Breast Pathology by the International Society of Breast Pathology in 2018.

Prof Jane Visvader, BSc (Hons), PhD Adelaide. The Walter and Eliza Hall Institute of Medical Research, Australia

Prof Jane Visvader is joint head of the ACRF Cancer Biology and Stem Cells Division at the Walter and Eliza Hall Institute (WEHI). She obtained her PhD at the University of Adelaide. Following postdoctoral work at the Salk Institute and the WEHI, she took an appointment as a Harvard Medical School Instructor in Boston before she was recruited back by the prestigious Victorian Breast Cancer Research Consortium to establish a Breast Cancer Laboratory.

Prof Visvader’s team have made important contributions to the mammary biology and breast cancer fields by isolating mammary stem cells, defining master regulators of mammary gland development and identifying genetic lesions that drive oncogenesis. She published a milestone study in Nature in 2006 describing the successful isolation of the long-sought mouse mammary stem cell. She also revealed that breast stem cells are highly responsive to steroid hormone signalling, despite lacking hormone receptors, thus explaining the long-established epidemiological link between hormone exposure and breast cancer. She defined several master regulators in cell fate decisions in the mammary gland, providing an indispensable framework for understanding mammary lineage commitment and differentiation. Her group subsequently proved the existence of an analogous hierarchy in human breast and derived unique gene signatures for the different subpopulations. This work led to the discovery that aberrant luminal progenitors, rather than stem cells, are the transformation target in BRCA1- associated basal tumours.

Prof Visvader is a Fellow of the Australian Academy of Science and the recipient of a NHMRC Australia Fellowship. She has received many prestigious awards, including the Tschira Stiftung Lectureship (German Cancer Centre), the Royal Society of Victoria Medal for Excellence in Research, and the Brinker Award for Scientific Distinction in Basic Science (joint award). She was also awarded the Lemberg Medal by the Australian Society for Biochemistry and Molecular Biology in 2016.

5 | P a g e





Prof Ross Lawrenson, Waikato District Health Board & University of Waikato, New Zealand

Professor Ross Lawrenson, MBBS London, MD London, FRCGP, FFPH FAFPHM, is Professor of Population Health at the University of Waikato, New Zealand. He is an epidemiologist and public health physician, whose main research interest is identifying ways of improving outcomes for cancer. He has worked both in the United Kingdom and in New Zealand as an academic and health services researcher. He has published a textbook on Epidemiology and Public Health Medicine and authored over 180 peer-reviewed papers. He is a former Chair of the National Screening Advisory Committee and a board member of the New Zealand Cancer Health Information Strategy and PHARMAC committees.

Prof Sarah-Jane Dawson, Peter MacCallum Cancer Centre & The University of Melbourne, Australia

Professor Sarah-Jane Dawson, MBBS (Hons), FRACP, PhD (Cantab), is a clinician-scientist. She obtained her medical degree from the University of Melbourne in 1998, and trained as a medical oncologist in Melbourne, Australia. She completed her PhD at the University of Cambridge, UK. Following postdoctoral studies at the Cancer Research UK Cambridge Institute, she returned to Melbourne in 2014 to head the Molecular Biomarkers and Translational Genomics Laboratory at the Peter MacCallum Cancer Centre. She also holds a joint appointment with the Centre of Cancer Research at The University of Melbourne (since 2016) and currently holds a CSL Centenary Fellowship (2018-2022). Her current research interests are focused on the development of noninvasive blood-based biomarkers ('liquid biopsies') for clinical application, including early detection, risk stratification and disease monitoring in cancer management.

Distinguished Prof Stephen Hursting, University of North Carolina at Chapel Hill, the USA

Dr Stephen Hursting is the AICR/WCRF Distinguished Professor in the Department of Nutrition at the University of North Carolina (UNC) at Chapel Hill. He is also Professor at the UNC Nutrition Research Institute and the UNC Lineberger Comprehensive Cancer Center. He earned his PhD in nutritional biochemistry and MPH in nutritional epidemiology from UNC-Chapel Hill, and he completed postdoctoral training in molecular carcinogenesis and cancer prevention at the National Cancer Institute (NCI). Prior to joining the UNC faculty in 2014, Dr Hursting was Professor and Chair of the Department of Nutritional Sciences at the University of Texas (UT) at Austin, the McKean-Love Endowed Chair of Nutritional, Molecular and Cellular Sciences in the UT College of Natural Sciences, and Professor of Molecular Carcinogenesis at the UT-MD Anderson Cancer Center (2005-14). He also previously served as Chief of the NCI’s Nutrition and Molecular Carcinogenesis Laboratory Section (2000-2005) and Deputy Director of the NCI’s Cancer Prevention Fellowship Program (1999-2005). His research interests center on precision nutrition as applied to cancer prevention, particularly the molecular and metabolic mechanisms underlying obesity- cancer associations, and the interplay between obesity, metabolism, host genetics and cancer. Primarily using preclinical models (including human and mouse cell lines, genetically engineered mouse models of cancer, and genetically heterogeneous Collaborative Cross mice) in parallel with human studies, he is currently focusing on the molecular and metabolic changes occurring in response to lifestyle-based (dietary and physical activity); surgical (bariatric surgery), or pharmacologic manipulation of energy metabolism and cell signalling pathways. His lab is establishing that targeting growth factor signalling pathways, inflammation and the gut microbiome can reverse the procancer effects of obesity.

6 | P a g e





Moments

in

NZBCS-2017

7 | P a g e





Platinum Gold Silver Bronze

Acknowledgement opportunities

Verbal acknowledgement during technical session

Written acknowledgement on screen in technical session

Written acknowledgement on official NZBCS website

Written acknowledgement in conference handbook

Advertising opportunities

1 x trade display booth Deluxe Deluxe Standard Standard

Pull-up banner on display (provided by you)

Your logo branded on lanyards

Your logo branded on cover of conference handbook

Advertisement in conference handbook Full-page Half-page One quarter-

page

Your logo on screen during technical session

Your logo on official NZBCS website

Your link on official NZBCS website

Your bio on official NZBCS website 250 words 150 words

Satchel insert

Permitted use of NZABC® logo on your own material

Technical session opportunities

Naming rights to a technical session

Keynote speaking opportunity

Registration opportunities

Complimentary conference registration 4 2 1 1

COST (NZ+GST) $20,000 $10,000 $5,000 $3,000

8 | P a g e





This sponsorship package is limited to one organisation:

Acknowledgement opportunities: o Verbal acknowledgement of platinum sponsorship during technical session o Written acknowledgement of platinum sponsorship on screen during technical

session o Written acknowledgement of platinum sponsorship on official NZBCS website o Written acknowledgement of platinum sponsorship in conference handbook

Advertising opportunities: o 1 x deluxe trade display booth o Pull-up banner on display (provided by you) o Your logo branded on lanyards worn by delegates o Your logo branded on the cover of the conference handbook o A full-page advertisement in the conference handbook o Your logo on screen during technical session o Your logo, link and bio (250 words) on the official NZBCS website o A satchel insert (provided at your discretion) o Permitted use of NZBCS logo on your own online and printed material

Technical session opportunities: o Naming rights to a technical session o Keynote speaking opportunity (duration to be advised)

Registration opportunities: 4 full complimentary registrations to attend the conference

This sponsorship package is limited to two organisations:

Acknowledgement opportunities: o Verbal acknowledgement of gold sponsorship during technical session o Written acknowledgement of gold sponsorship on screen during technical session o Written acknowledgement of gold sponsorship on official NZBCS website o Written acknowledgement of gold sponsorship in conference handbook

Advertising opportunities: o 1 x deluxe trade display booth o Pull-up banner on display (provided by you) o Your logo branded on the cover of the conference handbook o A half-page advertisement in the conference handbook o Your logo on screen during technical session o Your logo, link and bio (150 words) on the official NZBCS website o A satchel insert (provided at your discretion) o Permitted use of NZBCS logo on your own online and printed material


Registration opportunities: 2 full complimentary registrations to attend the conference

GOLD SPONSOR: NZD $10,000 (+ GST)

PLATINUM SPONSOR: NZD $20,000 (+ GST)

9 | P a g e





This sponsorship package is limited to four organisations:

Acknowledgement opportunities: o Verbal acknowledgement of silver sponsorship during technical session o Written acknowledgement of silver sponsorship on screen during technical session o Written acknowledgement of silver sponsorship on official NZBCS website o Written acknowledgement of silver sponsorship in conference handbook

Advertising opportunities: o 1 x standard trade display booth o Pull-up banner on display (provided by you) o Your logo branded on the cover of the conference handbook o A quarter-page advertisement in the conference handbook o Your logo on screen during technical session o Your logo and link on the official NZBCS website o A satchel insert (provided at your discretion)


Registration opportunities: 1 full complimentary registration to attend the conference

This sponsorship package is limited to four institutions:

Acknowledgement opportunities: o Verbal acknowledgement of bronze sponsorship during a technical session o Written acknowledgement of bronze sponsorship on official NZBCS website o Written acknowledgement of bronze sponsorship in conference handbook

Advertising opportunities: o 1 x standard trade display booth o Pull-up banner on display (provided by you) o Your logo branded on the cover of the conference handbook o Your logo and link on the official NZBCS website o A satchel insert (provided at your discretion)

Registration opportunities: 1 full complimentary registration to attend the conference

SILVER SPONSOR: NZD $5,000 (+ GST)

BRONZE SPONSOR: NZD $3,000 (+ GST)

10 | P a g e





There is also opportunity to sponsor the following functions at the conference:

Function type Max

allocation Price (NZD)

Complimentary registration

Morning tea 3 $2,000

Afternoon tea 3 $2,000

Lunch 3 $5,000 1

Welcome reception cocktail party 1 $4,000

Conference Dinner 1 $10,000 2

These function sponsorships will give your company or institution the opportunity to:

Acknowledge your function sponsorship by: o Written acknowledgement in conference handbook o Verbal acknowledgement during the catering event o Visual displays, signage and advertising during the catering event

Conduct prize draws and other promotional activities during the catering events Distribute appropriate promotional materials during the catering events

Please email at [email protected] for further details:

Advertising in conference handbook:

o Full page $150+GST o Half page $100+GST o Quarter page $50+GST

Provision of:

o Satchel inserts o Promotional satchels o Nametags o Notepads and pens o Other appropriate promotional materials

Receive complimentary conference registrations (for dinner and lunch only)

FUNCTION SPONSOR:

ONE-OFF OPPORTUNITIES:

11 | P a g e





(Please email to [email protected])

Company ……………...………………………………………………………………………………………..

Contact Name ……………..…………………………………………………………………………………...

Position ………………………………………………………………………………………………………....

Address …………………………………………………………………………………………………………

Post Code ……………………...

Telephone ………………..………………………… Fax ………………..………………………………..

Email ………………..…………………………………………………………………………………………...

I would like to invest in (please select)

Platinum Sponsorship: NZD $20,000

Gold Sponsorship: NZD $10,000

Silver Sponsorship: NZD $5,000

Bronze Sponsorship: NZD $3,000

Function Sponsorship: NZD $...........

Other One-off Opportunities: NZD $...........

I/We have read and agree with the terms and conditions on next page of this prospectus.

Please invoice my organisation.

SPONSORSHIP DETAILS:

SPONSORSHIP LEVEL:

12 | P a g e





CURRENCY: All prices are exclusive of GST unless otherwise specified, and are quoted in New Zealand Dollars.

PAYMENT: All sponsorship and exhibitor payments must be paid to:

Account Name: New Zealand Association of Breast Cancer Research Incorporated.

Account Number: 03-0296-0456700-000

Bank Details: Westpac, Mid City, 229-231 Queen Street, Auckland, New Zealand

A tax invoice will be issued to ensure that any tax benefits associated with the money received from the sponsorship package are available to registered New Zealand businesses.

Please note payment must be made in full before logos and/or company names are included on the website/programme prior to the Symposium or access may be denied.

REGULATIONS:

Any sound utilised on a stand is to remain at a low level so as not to interfere with other exhibitors.

Promotional material should not interfere with or dominate other booths. Material may not be suspended from the ceiling of the exhibition booth area.

The exhibitor is financially responsible for any loss or damage caused to the property or equipment by organisers and guests before, during and after the event. This includes failure to return equipment such as power boards, cables and other such items.

It is the responsibility of each exhibitor to ensure that their stand and goods on display are adequately insured for theft and damage.

Only food provided by AUT Hospitality Services can be served onsite during the symposium.

ALLOCATION OF EXHIBITION SPACE: The Exhibition spaces will be allocated by AUT Hospitality Services according to the type of exhibitor package and on a first come, first served basis.

CANCELLATION: A sponsor or exhibitor must inform the Symposium Organisers if they wish to cancel their sponsorship or confirmed exhibition space. The cancellation will become effective upon receipt of written notice from the sponsor or exhibitor.

If a sponsor or exhibitor cancels before Oct 01, 2021, a cancellation fee of 50% of your total sponsorship/exhibition package will apply. If a sponsor or exhibitor cancels after Oct 01, 2021, a cancellation fee of 100% of your total sponsorship/exhibition package will apply.

SYMPOSIUM CANCELLATION: If for any reason the Symposium is cancelled altogether, then New Zealand Association of Breast Cancer Research Incorporated shall not be liable for any expenses that you may incur in relation to termination of the exhibition.

Sponsorship Prospectus V3.0nzbcs.org.nz/uploads/NZBCS2020/sponsorshipprospectus2021.pdfSociety of...

Documents

Transcript of Sponsorship Prospectus V3.0nzbcs.org.nz/uploads/NZBCS2020/sponsorshipprospectus2021.pdfSociety of...